Nuri Gueven Selected Research

Neoplasms (Cancer)

12/2023	Exploring Lin28 proteins: Unravelling structure and functions with emphasis on nervous system malignancies.
1/2023	LIN28 expression and function in medulloblastoma.
10/2021	Opioid Analgesia and Opioid-Induced Adverse Effects: A Review.
2/2020	Micro RNA Expression after Ingestion of Fucoidan; A Clinical Study.
1/2019	Pathway Analysis of Fucoidan Activity Using a Yeast Gene Deletion Library Screen.
1/2014	Identification of pro- and anti-proliferative oligosaccharides of heparins.
7/2008	Defective responses to DNA single- and double-strand breaks in spinocerebellar ataxia.
9/2006	Dramatic extension of tumor latency and correction of neurobehavioral phenotype in Atm-mutant mice with a nitroxide antioxidant.
1/2005	ATM signaling and genomic stability in response to DNA damage.
8/2002	Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nuri Gueven Research Topics

Disease

10	Neoplasms (Cancer) 12/2023 - 08/2002
10	Ataxia Telangiectasia (Louis Bar Syndrome) 09/2015 - 08/2002
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 03/2011
6	Colitis 01/2021 - 01/2015
5	Body Weight (Weight, Body) 01/2021 - 01/2015
5	Inflammation (Inflammations) 01/2021 - 01/2015
5	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 01/2016
4	Genomic Instability 07/2008 - 08/2002
3	Hemorrhage 01/2023 - 01/2015
3	Ulcerative Colitis 01/2020 - 01/2015
3	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2019 - 09/2006
3	Ataxia (Dyssynergia) 05/2013 - 06/2007
2	Pain (Aches) 06/2022 - 10/2021
2	Medulloblastoma 05/2022 - 11/2020
2	Optic Nerve Diseases (Optic Neuropathy) 01/2022 - 06/2016
2	Gliosis 01/2021 - 01/2012
2	Disease Progression 01/2021 - 01/2016
2	autosomal recessive 1 Spinocerebellar ataxia 05/2013 - 07/2006
2	Apraxias (Dyspraxia) 03/2010 - 06/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2006 - 08/2004
1	Brain Edema (Cerebral Edema) 01/2023
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023
1	Glioma (Gliomas) 05/2022
1	Angina Pectoris 05/2022
1	Hypertension (High Blood Pressure) 05/2022
1	Chronic Pain 10/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Herpes Zoster 01/2021
1	Dementia (Dementias) 01/2021
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2020
1	Relapsing-Remitting Multiple Sclerosis 10/2020
1	Wasting Syndrome (Wasting Disease) 01/2020
1	Necrosis 10/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Vision Disorders (Hemeralopia) 06/2016
1	Edema (Dropsy) 01/2015
1	Diarrhea 01/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 12/2023 - 08/2002
8	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 08/2002
6	QuinonesIBA 03/2021 - 03/2011
6	idebenoneIBA 01/2021 - 03/2011
3	quinone (benzoquinone)IBA 03/2021 - 02/2020
3	Retinaldehyde (Retinal)IBA 01/2021 - 01/2012
3	SodiumIBA 01/2021 - 01/2015
3	Dextrans (Dextran)FDA Link 01/2021 - 01/2015
3	Metformin (Glucophage)FDA LinkGeneric 10/2019 - 01/2016
3	AnticoagulantsIBA 01/2015 - 01/2015
3	Enoxaparin (Lovenox)FDA LinkGeneric 01/2015 - 01/2014
2	Opioid Analgesics (Opioids)IBA 06/2022 - 10/2021
2	NaphthoquinonesIBA 01/2021 - 03/2019
2	AntioxidantsIBA 01/2020 - 09/2006
2	CitrullineIBA 10/2019 - 01/2016
2	Arginine (L-Arginine)FDA Link 10/2019 - 01/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2019 - 01/2016
2	fucoidanIBA 01/2019 - 01/2015
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2015 - 01/2015
2	Complementary DNA (cDNA)IBA 05/2004 - 01/2004
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023
1	Neuroprotective AgentsIBA 01/2023
1	Heparin (Liquaemin)FDA LinkGeneric 01/2023
1	Analgesics (Analgesic Drugs)IBA 06/2022
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 05/2022
1	MibefradilIBA 05/2022
1	Oxyquinoline (8 Hydroxyquinoline)FDA Link 01/2022
1	Clioquinol (Vioform)FDA Link 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	OccludinIBA 01/2021
1	CalciumIBA 01/2021
1	AgarIBA 11/2020
1	Dimethyl FumarateIBA 10/2020
1	MucinsIBA 09/2020
1	Cell Surface ReceptorsIBA 02/2020
1	DystrophinIBA 01/2020
1	adenylosuccinateIBA 01/2020
1	Mucin-2IBA 01/2020
1	ProteomeIBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019
1	Amino Acids FDA Link 10/2019
1	Biomarkers (Surrogate Marker)IBA 10/2019
1	BiguanidesIBA 10/2019
1	AmidesIBA 03/2019
1	FucoseIBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	VenomsIBA 01/2018
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2016
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 09/2015
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 09/2015
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2015
1	DisaccharidesIBA 01/2015
1	CytokinesIBA 01/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2006
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2015